Skip to content
All Sections
Subscribe Now
92°F
Friday, September 27th 2024
Today's E-Edition
Home Page
Close Menu
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
SUBSCRIBE NOW
Close Menu
Morning Report in your inbox!
Sign Up
Subscribe
Account Settings
Contact Us
Log Out
Spoof a user
Morning Report in your inbox!
Sign Up
Subscribe
Search
Silicon Valley
92°F
Friday, September 27th 2024
Today's E-Edition
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ResMed Inc.
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
September 10, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Vaping Expected to Increase COPD Health and Economic Burden by 2050
September 10, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 28, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
August 15, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
August 01, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
July 03, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
June 10, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
May 23, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
May 16, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the RBCCM Global Healthcare Conference
May 07, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
April 25, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
April 04, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
March 15, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
March 06, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
February 12, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
January 24, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
January 03, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
December 20, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Secures Significant Victory in Patent Fight Against New York University
December 11, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
December 07, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Adopts New Operating Model to Accelerate Long-term Growth
November 09, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
October 26, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
October 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in Upcoming Conferences
September 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
August 03, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
July 06, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
July 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
June 08, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference
June 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close